Literature DB >> 30835266

Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection.

Louisa A Carlisle1,2, Teja Turk1,2, Katharina Kusejko1,2, Karin J Metzner1,2, Christine Leemann1,2, Corinne D Schenkel1,2, Nadine Bachmann1,2, Susana Posada3,4, Niko Beerenwinkel3,4, Jürg Böni2,5, Sabine Yerly6, Thomas Klimkait7, Matthieu Perreau8, Dominique L Braun1,2, Andri Rauch9, Alexandra Calmy6, Matthias Cavassini10, Manuel Battegay11, Pietro Vernazza12, Enos Bernasconi13, Huldrych F Günthard1,2, Roger D Kouyos1,2.   

Abstract

BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) genetic diversity increases over the course of infection and can be used to infer the time since infection and, consequently, infection recency, which are crucial for HIV-1 surveillance and the understanding of viral pathogenesis.
METHODS: We considered 313 HIV-infected individuals for whom reliable estimates of infection dates and next-generation sequencing (NGS)-derived nucleotide frequency data were available. Fractions of ambiguous nucleotides, obtained by population sequencing, were available for 207 samples. We assessed whether the average pairwise diversity calculated using NGS sequences provided a more exact prediction of the time since infection and classification of infection recency (<1 year after infection), compared with the fraction of ambiguous nucleotides.
RESULTS: NGS-derived average pairwise diversity classified an infection as recent with a sensitivity of 88% and a specificity of 85%. When considering only the 207 samples for which fractions of ambiguous nucleotides were available, the NGS-derived average pairwise diversity exhibited a higher sensitivity (90% vs 78%) and specificity (95% vs 67%) than the fraction of ambiguous nucleotides. Additionally, the average pairwise diversity could be used to estimate the time since infection with a mean absolute error of 0.84 years, compared with 1.03 years for the fraction of ambiguous nucleotides.
CONCLUSIONS: Viral diversity based on NGS data is more precise than that based on population sequencing in its ability to predict infection recency and provides an estimated time since infection that has a mean absolute error of <1 year.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV-1; diversity; infection recency; next-generation sequencing; time since infection

Year:  2019        PMID: 30835266     DOI: 10.1093/infdis/jiz094

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

1.  Near Real-Time Identification of Recent Human Immunodeficiency Virus Transmissions, Transmitted Drug Resistance Mutations, and Transmission Networks by Multiplexed Primer ID-Next-Generation Sequencing in North Carolina.

Authors:  Shuntai Zhou; Sabrina Sizemore; Matt Moeser; Scott Zimmerman; Erika Samoff; Victoria Mobley; Simon Frost; Andy Cressman; Michael Clark; Tara Skelly; Hemant Kelkar; Umadevi Veluvolu; Corbin Jones; Joseph Eron; Myron Cohen; Julie A E Nelson; Ronald Swanstrom; Ann M Dennis
Journal:  J Infect Dis       Date:  2021-03-03       Impact factor: 5.226

2.  Long-read sequencing reveals the evolutionary drivers of intra-host diversity across natural RNA mycovirus infections.

Authors:  Deborah M Leigh; Karla Peranić; Simone Prospero; Carolina Cornejo; Mirna Ćurković-Perica; Quirin Kupper; Lucija Nuskern; Daniel Rigling; Marin Ježić
Journal:  Virus Evol       Date:  2021-12-01

3.  Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.

Authors:  Alexandre Nicolas; Julie Migraine; Jacques Dutrieux; Maud Salmona; Alexandra Tauzin; Atsuko Hachiya; Jérôme Estaquier; Jean-Michel Molina; François Clavel; Allan J Hance; Fabrizio Mammano
Journal:  Microbiol Spectr       Date:  2022-06-30

4.  Epidemiological and viral characteristics of undiagnosed HIV infections in Botswana.

Authors:  Lynnette Bhebhe; Sikhulile Moyo; Simani Gaseitsiwe; Molly Pretorius-Holme; Etienne K Yankinda; Kutlo Manyake; Coulson Kgathi; Mompati Mmalane; Refeletswe Lebelonyane; Tendani Gaolathe; Pamela Bachanas; Faith Ussery; Mpho Letebele; Joseph Makhema; Kathleen E Wirth; Shahin Lockman; Max Essex; Vlad Novitsky; Manon Ragonnet-Cronin
Journal:  BMC Infect Dis       Date:  2022-08-28       Impact factor: 3.667

5.  HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection.

Authors:  Louisa A Carlisle; Teja Turk; Karin J Metzner; Herbert A Mbunkah; Cyril Shah; Jürg Böni; Michael Huber; Dominique L Braun; Jan Fehr; Luisa Salazar-Vizcaya; Andri Rauch; Sabine Yerly; Aude Nguyen; Matthias Cavassini; Marcel Stoeckle; Pietro Vernazza; Enos Bernasconi; Huldrych F Günthard; Roger D Kouyos
Journal:  Viruses       Date:  2020-10-31       Impact factor: 5.048

6.  Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana.

Authors:  Manon Ragonnet-Cronin; Tanya Golubchik; Sikhulile Moyo; Christophe Fraser; Max Essex; Vlad Novitsky; Erik Volz
Journal:  J Infect Dis       Date:  2022-04-19       Impact factor: 7.759

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.